This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).
- Investigator
- Jeb M Justice
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).
The primary objectives of the study are: To longitudinally characterize the long-term effectiveness of DUPIXENT庐 through assessment of patient-reported symptoms, Health-Related Quality of Life (HRQoL) related to Chronic rhinosinusitis with nasal鈥�
37 publications
2025
International Forum of Allergy & Rhinology
2024
Cleveland Clinic journal of medicine
鈥�2024
The American journal of tropical medicine and hygiene
鈥�2024
Journal of neurological surgery. Part B, Skull base
鈥�2023
Cureus
鈥�